Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People (NO-GARROT)

January 16, 2024 updated by: Hôpital NOVO

Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People : Randomized Trial

This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.

Study Overview

Detailed Description

Almost 3 million people aged 70 and over are hospitalized once or more each year. The implementation of multiple treatments in these fragile patients, often poly-pathological requires a regular biological monitoring. For these patients, samples must be taken on average every two days.

This population often has a fragile venous capital due to reduced skin elasticity, undernutrition more or less associated with dehydration, the use of certain venous-toxic treatments and / or repetition of the gesture taking into account the monitoring biological closely related to long-term therapies.

With the aim of well-treatment and well-being, the reduction of patient pain is one of the major concerns of caregivers and in particular pain induced by treatment.

In children, the practice of harvesting without tourniquet is already frequent (18) and our preliminary study has confirmed us on the tourniquet as one of the acts responsible for the pain that the caregiver can possibly abstain.

No study had been conducted on this subject in the adult population and more particularly the elderly population. This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.

Study Type

Interventional

Enrollment (Estimated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Mathilde Wlodarczyk
  • Phone Number: 7199 0033130754040

Study Contact Backup

Study Locations

      • Brest, France, 29600
        • Active, not recruiting
        • Geriatric Department - CHRU Brest
      • Cholet, France, 49 300
      • Colombes, France, 92700
        • Recruiting
        • Geriatric Department - Hospital Louis Mourier - Colombes
        • Contact:
      • Créteil, France, 94010
        • Recruiting
        • Geriatric Department - Intercommunal hospital center - Créteil
        • Contact:
      • Pontoise, France, 95300
        • Recruiting
        • Geriatric Department - Hospital René Dubos - Pontoise
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ≥ 75 years and over,
  • Hospitalized in internal medicine or geriatric department,
  • For which the 2 upper limbs are accessible to venous puncture (due to the multiple attempts that may be necessary to take a sample during the hospitalization),
  • For which at least one vein is visible or palpable on an upper limb,
  • Without venous puncture since admission in the department,
  • Patient who did not receive a topical anesthetic before the venous puncture (Emla type)
  • Communicating patient, able to assess their pain on a digital scale,
  • Patients with affiliation to a social security system or beneficiary ,
  • Written informed consent (IC) obtained.

Exclusion Criteria:

  • Patient already included,
  • Previous pain localized to the upper limbs,
  • Hematoma at the planned site of skin-vascular breakage,
  • Hemiplegic or quadriplegic patient,
  • Patient with lymphedema in the upper limbs,
  • Patient with behavioral disorders that may interfere with the proper functioning of the sampling,
  • Patient with cognitive impairment preventing understanding of the study and adequate assessment pain (CODEX cognitive score of category C or D),
  • Patient placed under legal protection (guardianship).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rubber tourniquet
The blood sample is taken with a rubber tourniquet,
The blood sample is taken with a rubber tourniquet
Experimental: Fabric tourniquet
The blood sample is taken with a a fabric tourniquet
The blood sample is taken with a fabric tourniquet
Experimental: No tourniquet
The blood sample is taken without tourniquet
The blood sample is taken without tourniquet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of the maximum pain associated with venous puncture, in elderly patients with a visible or palpable vein depending on the method of sampling.
Time Frame: At the end of the study, an average of 12 month

Assessment of maximum pain on examination (including pain from skin-vascular invasion and tourniquet pain)by the patient using a verbal numerical scale (EN) rated from 0 to 10.

This measure concerns the 1st sampling as a whole, regardless of the number of attempts necessary to obtain it and their terms

At the end of the study, an average of 12 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of elderly patients with a visible or palpable vein
Time Frame: At the end of the study, an average of 12 month
Estimate of the proportion of patients corresponding to phlebological prerequisites of the study (vein visible or palpable on at least one of the two upper limbs) on all elderly people meeting the other selection criteria upon admission to the service for the duration of the research
At the end of the study, an average of 12 month
Comparison of the number of cutaneous-vascular breaks necessary for obtain a blood sample, according to the venous sampling procedure
Time Frame: At the end of the study, an average of 12 month
Compilation of the number of cutaneous-vascular ruptures performed until obtention of a sample sent to laboratory
At the end of the study, an average of 12 month
Comparison of the time taken to obtain a blood sample by caregivers, according to the venous sampling procedures
Time Frame: At the end of the study, an average of 12 month
Measurement of the time required for this sample using timing from the moment the nurse is ready and until the end of the filling of the first tube sampled. This timing is performed by the caregiver himself and not by the third party who will collect the patient's pain and who is not present, in order to avoid any external influence linked to the performance of the gesture during the evaluation of the main criterion
At the end of the study, an average of 12 month
Comparison of the ease of taking the sample by caregivers, according to the venous sampling procedure
Time Frame: At the end of the study, an average of 12 month

Collection of the ease of performing the sampling by the caregivers via a Likert-type question (very easy, rather easy, rather difficult, very difficult) filled in after each sampling.

In addition, the need to change arms or to call on another caregiver to perform the procedure will be noted.

At the end of the study, an average of 12 month
Estimation of the pain due to the tourniquet and to the cutaneous-vascular breaks in patients where sample was taken with tourniquet
Time Frame: At the end of the study, an average of 12 month

Verbal numerical scale measurements of tourniquet pain and pain due to vascular break (groups with tourniquet only).

0 = No pain, 5 = moderate pain and 10 = Worst possible pain.

At the end of the study, an average of 12 month
Comparison of the frequency of side effects: malaise, hematoma at the cutaneous-vascular break site, according to the venous sampling procedure ; hematoma and / or skin abrasion at the tourniquet, in patients collected with tourniquet
Time Frame: At the end of the study, an average of 12 month
The presence of hematoma (s) will be observed in each group the next day of the sample by a caregiver separate from the one who performed the sample. The caregiver will also note the presence of skin abrasions related to possible use of tourniquet. Other unwanted events will also be collected, in particular: vagal unease during or after the sample, hemorrhage, ...
At the end of the study, an average of 12 month
Comparison of the frequency of hemolysis of the sample, according to the venous sampling procedure
Time Frame: At the end of the study, an average of 12 month
Proportion of samples having to be carried out again for hemolysis
At the end of the study, an average of 12 month
Estimation of the influence of the nurse's experience on the efficiency of venous sampling on the duration of blood collection
Time Frame: At the end of the study, an average of 12 month

Estimation of the effect of the mode of venipuncture (arm), according to the experience of the nurse on the duration of blood collection.

The duration of the blood sampling is expressed in minute.

At the end of the study, an average of 12 month
Estimation of the influence of the nurse's experience on the efficiency of venous sampling on pain
Time Frame: At the end of the study, an average of 12 month

Estimation of the effect of the mode of venipuncture (arm), according to the experience of the nurse on pain.

Verbal numerical scale measurements was used : 0 = No pain, 5 = moderate pain and 10 = Worst possible pain.

At the end of the study, an average of 12 month
Estimation of the influence of the type of material used on the efficiency of venous sampling on pain
Time Frame: At the end of the study, an average of 12 month

Estimation of the effect of the mode of venipuncture (arm), according to the type of material (butterfly needle, diameter) on pain.

Verbal numerical scale measurements was used : 0 = No pain, 5 = moderate pain and 10 = Worst possible pain.

At the end of the study, an average of 12 month
Estimation of the influence of the type of material used on the efficiency of venous sampling on the duration of blood collection
Time Frame: At the end of the study, an average of 12 month

Estimation of the effect of the mode of venipuncture (arm), according to the type of material (butterfly needle, diameter) on the duration of blood collection.

The duration of the blood sampling is expressed in minute.

At the end of the study, an average of 12 month
Frequency of failures (regardless of the venous sampling method used) and refusal of the sample venous without tourniquet
Time Frame: At the end of the study, an average of 12 month
Number of failures (regardless of the venous sampling method used) and refusal of the sample venous without tourniquet
At the end of the study, an average of 12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Vella QUILLIEN, Hospital René Dubos - Pontoise

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2022

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

December 15, 2021

First Submitted That Met QC Criteria

February 4, 2022

First Posted (Actual)

February 7, 2022

Study Record Updates

Last Update Posted (Actual)

January 17, 2024

Last Update Submitted That Met QC Criteria

January 16, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CHRD0319
  • 2021-A02936-35 (Other Identifier: ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venous Puncture

Clinical Trials on Rubber tourniquet

3
Subscribe